Home » Think Tank: U.S. FDA Off-Label Sharing Rules Too Restrictive
Think Tank: U.S. FDA Off-Label Sharing Rules Too Restrictive
December 16, 2014
Recent U.S. Food and Drug Administration guidance on distributing scientific publications that cover off-label uses is out of touch with today’s data-driven economy and should be modified to embrace digital communication platforms, a Washington, D.C., think tank says.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor